Crispr Therapeutics (CRSP) Financial Articles

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise... Read More

Industry: Biotechnology Sector: Healthcare

Currently in review using our new methodology check back by end of Jan 2022

Crispr Therapeutics (CRSP)

Entirely Comfortable

Business Score

Financial Score

ESG Score

Report Summary

None of the business's revenue comes from Haram.
Interest is not used while running the company.
The company has a substantial positive impact on the environment, society and governance.

What are Halal Investors' Comfort Levels?

Our Comfort Levels are based on our analysts’ latest review of a company's business, finances, and Environmental, Social and Governance (ESG) Impact. Our reports are not meant to be understood as a religious ruling (fatwa). Rather, they represent our best efforts in trying to identify whether a company is engaged in anything forbidden in Islam (haram) and to what extent. Based on our analysis, we determine our Comfort Level with investing in the company. We encourage readers to let us know if we missed anything in the comments and to voice their agreement/disagreement by leaving a thumbs up/down. Read more about our methodology.